Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
14.03
-0.25 (-1.75%)
Nov 20, 2026, 3:00 PM CST
SHA:600535 Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, SHA:600535 stock has a consensus rating of "Buy" and an average price target of ¥16.73. The average 1-year stock price forecast is 19.24% higher than the current stock price, while the lowest is ¥14.00 (-0.21%) and the highest is ¥18.00 (+28.30%).
Price Target: ¥16.73 (+19.24%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SHA:600535 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 6 |
Financial Forecast
Revenue This Year
8.52B
from 8.24B
Increased by 3.44%
Revenue Next Year
9.20B
from 8.52B
Increased by 7.95%
EPS This Year
0.84
EPS Next Year
0.95
from 0.84
Increased by 13.10%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.